Pharmacological and biochemical studies on the possible role of nitric oxide in stress adaptation in rats
The involvement of nitric oxide (NO) in stress adaptation was evaluated in rats using the elevated plus maze test. Repeated restraint stress RS(×5) for 5 days resulted in an increase in the percentage number of entries and percentage time spent when compared to a single restraint stress RS(×1) expos...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 2004-06, Vol.493 (1), p.111-115 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 115 |
---|---|
container_issue | 1 |
container_start_page | 111 |
container_title | European journal of pharmacology |
container_volume | 493 |
creator | Masood, Anbrin Banerji, Basudeb Vijayan, V.K. Ray, Arunabha |
description | The involvement of nitric oxide (NO) in stress adaptation was evaluated in rats using the elevated plus maze test. Repeated restraint stress RS(×5) for 5 days resulted in an increase in the percentage number of entries and percentage time spent when compared to a single restraint stress RS(×1) exposure. In the repeated RS treatment groups, the nitric oxide donor,
l-arginine (500 and 1000 mg/kg, i.p.) slightly increased the elevated plus maze test parameters when compared to the corresponding vehicle-treated group. The nitric oxide synthase (NOS) inhibitors,
N-nitro-
l-arginine methyl ester (
l-NAME, 10 and 50 mg/kg, i.p.) and 7-nitroindazole (10 and 50 mg/kg, i.p.) produced differential responses in both the parameters with
l-NAME exhibiting greater reduction in open arm entries and open arm time, whereas 7-nitroindazole produced only small differences in both the elevated plus maze parameters. Biochemical data showed that repeated restraint stress resulted in higher levels of brain nitrates and nitrites (NO
x) as compared to that of single restraint stress exposure. Further, in
l-arginine (1000 mg/kg, i.p.)-treated rats, brain NO
x was lowest in the single restraint stress group, followed by repeated restraint stress and (no restraint stress) controls. The results are suggestive of the role of nitric oxide in stress adaptation and this may be due to the effects of restraint stress on brain NOS activity. |
doi_str_mv | 10.1016/j.ejphar.2004.04.018 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72014141</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299904004030</els_id><sourcerecordid>72014141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-3bbb58930f3f2ecdde66b24828417be63540cedd944333afeed7acd19e571f1b3</originalsourceid><addsrcrecordid>eNp9kF1rHCEUhiW0JJuPf1CKN83dbHR0PrwplJCmhUBykVyLH2e6Z5kZp-qW9N_H7S60V8WDojzvwfMQ8oGzNWe8vdmuYbtsTFzXjMn1vnh_Qla871TFOl6_IyvGuKxqpdQZOU9pyxhrVN2ckjPe8F51HV8RfCotJuPCGH6gMyM1s6cWg9vA9Oee8s4jJBpmmjdAl5AS2hFoDGULA50xR3Q0vKIHinPhI6REjTdLNhlLrDxGk9MleT-YMcHV8bwgL1_vnm-_VQ-P999vvzxUTgqVK2GtbXol2CCGGpz30La2ln3dS95ZaEUjmQPvlZRCCDMA-M44zxU0HR-4FRfk-tB3ieHnDlLWEyYH42hmCLuku7pYKauA8gC6WIaKMOgl4mTib82Z3ivWW31QrPeK9b54X2Ifj_13dgL_N3R0WoBPR8CkYnCIZnaY_uF6JphoC_f5wEGx8Qsh6uQQ5jIcRnBZ-4D__8kbn6udsw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72014141</pqid></control><display><type>article</type><title>Pharmacological and biochemical studies on the possible role of nitric oxide in stress adaptation in rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Masood, Anbrin ; Banerji, Basudeb ; Vijayan, V.K. ; Ray, Arunabha</creator><creatorcontrib>Masood, Anbrin ; Banerji, Basudeb ; Vijayan, V.K. ; Ray, Arunabha</creatorcontrib><description>The involvement of nitric oxide (NO) in stress adaptation was evaluated in rats using the elevated plus maze test. Repeated restraint stress RS(×5) for 5 days resulted in an increase in the percentage number of entries and percentage time spent when compared to a single restraint stress RS(×1) exposure. In the repeated RS treatment groups, the nitric oxide donor,
l-arginine (500 and 1000 mg/kg, i.p.) slightly increased the elevated plus maze test parameters when compared to the corresponding vehicle-treated group. The nitric oxide synthase (NOS) inhibitors,
N-nitro-
l-arginine methyl ester (
l-NAME, 10 and 50 mg/kg, i.p.) and 7-nitroindazole (10 and 50 mg/kg, i.p.) produced differential responses in both the parameters with
l-NAME exhibiting greater reduction in open arm entries and open arm time, whereas 7-nitroindazole produced only small differences in both the elevated plus maze parameters. Biochemical data showed that repeated restraint stress resulted in higher levels of brain nitrates and nitrites (NO
x) as compared to that of single restraint stress exposure. Further, in
l-arginine (1000 mg/kg, i.p.)-treated rats, brain NO
x was lowest in the single restraint stress group, followed by repeated restraint stress and (no restraint stress) controls. The results are suggestive of the role of nitric oxide in stress adaptation and this may be due to the effects of restraint stress on brain NOS activity.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2004.04.018</identifier><identifier>PMID: 15189771</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adaptation ; Adaptation, Physiological - drug effects ; Adaptation, Physiological - physiology ; Animals ; Arginine - pharmacology ; Arginine - therapeutic use ; Biological and medical sciences ; Brain Chemistry - drug effects ; Drug Evaluation, Preclinical - methods ; Elevated plus maze ; Indazoles - pharmacology ; India ; Male ; Maze Learning - physiology ; Medical sciences ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitric Oxide - chemistry ; Nitric Oxide - physiology ; Nitric Oxide Synthase - antagonists & inhibitors ; Nitric Oxide Synthase - pharmacology ; NO (Nitric oxide) ; Pharmacology. Drug treatments ; Rats ; Rats, Wistar ; Restraint, Physical - adverse effects ; Restraint, Physical - methods ; Stress ; Stress, Physiological - drug therapy ; Stress, Physiological - metabolism ; Stress, Physiological - physiopathology</subject><ispartof>European journal of pharmacology, 2004-06, Vol.493 (1), p.111-115</ispartof><rights>2004 Elsevier B.V.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright 2004 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-3bbb58930f3f2ecdde66b24828417be63540cedd944333afeed7acd19e571f1b3</citedby><cites>FETCH-LOGICAL-c439t-3bbb58930f3f2ecdde66b24828417be63540cedd944333afeed7acd19e571f1b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014299904004030$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15803036$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15189771$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Masood, Anbrin</creatorcontrib><creatorcontrib>Banerji, Basudeb</creatorcontrib><creatorcontrib>Vijayan, V.K.</creatorcontrib><creatorcontrib>Ray, Arunabha</creatorcontrib><title>Pharmacological and biochemical studies on the possible role of nitric oxide in stress adaptation in rats</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>The involvement of nitric oxide (NO) in stress adaptation was evaluated in rats using the elevated plus maze test. Repeated restraint stress RS(×5) for 5 days resulted in an increase in the percentage number of entries and percentage time spent when compared to a single restraint stress RS(×1) exposure. In the repeated RS treatment groups, the nitric oxide donor,
l-arginine (500 and 1000 mg/kg, i.p.) slightly increased the elevated plus maze test parameters when compared to the corresponding vehicle-treated group. The nitric oxide synthase (NOS) inhibitors,
N-nitro-
l-arginine methyl ester (
l-NAME, 10 and 50 mg/kg, i.p.) and 7-nitroindazole (10 and 50 mg/kg, i.p.) produced differential responses in both the parameters with
l-NAME exhibiting greater reduction in open arm entries and open arm time, whereas 7-nitroindazole produced only small differences in both the elevated plus maze parameters. Biochemical data showed that repeated restraint stress resulted in higher levels of brain nitrates and nitrites (NO
x) as compared to that of single restraint stress exposure. Further, in
l-arginine (1000 mg/kg, i.p.)-treated rats, brain NO
x was lowest in the single restraint stress group, followed by repeated restraint stress and (no restraint stress) controls. The results are suggestive of the role of nitric oxide in stress adaptation and this may be due to the effects of restraint stress on brain NOS activity.</description><subject>Adaptation</subject><subject>Adaptation, Physiological - drug effects</subject><subject>Adaptation, Physiological - physiology</subject><subject>Animals</subject><subject>Arginine - pharmacology</subject><subject>Arginine - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Brain Chemistry - drug effects</subject><subject>Drug Evaluation, Preclinical - methods</subject><subject>Elevated plus maze</subject><subject>Indazoles - pharmacology</subject><subject>India</subject><subject>Male</subject><subject>Maze Learning - physiology</subject><subject>Medical sciences</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitric Oxide - chemistry</subject><subject>Nitric Oxide - physiology</subject><subject>Nitric Oxide Synthase - antagonists & inhibitors</subject><subject>Nitric Oxide Synthase - pharmacology</subject><subject>NO (Nitric oxide)</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Restraint, Physical - adverse effects</subject><subject>Restraint, Physical - methods</subject><subject>Stress</subject><subject>Stress, Physiological - drug therapy</subject><subject>Stress, Physiological - metabolism</subject><subject>Stress, Physiological - physiopathology</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kF1rHCEUhiW0JJuPf1CKN83dbHR0PrwplJCmhUBykVyLH2e6Z5kZp-qW9N_H7S60V8WDojzvwfMQ8oGzNWe8vdmuYbtsTFzXjMn1vnh_Qla871TFOl6_IyvGuKxqpdQZOU9pyxhrVN2ckjPe8F51HV8RfCotJuPCGH6gMyM1s6cWg9vA9Oee8s4jJBpmmjdAl5AS2hFoDGULA50xR3Q0vKIHinPhI6REjTdLNhlLrDxGk9MleT-YMcHV8bwgL1_vnm-_VQ-P999vvzxUTgqVK2GtbXol2CCGGpz30La2ln3dS95ZaEUjmQPvlZRCCDMA-M44zxU0HR-4FRfk-tB3ieHnDlLWEyYH42hmCLuku7pYKauA8gC6WIaKMOgl4mTib82Z3ivWW31QrPeK9b54X2Ifj_13dgL_N3R0WoBPR8CkYnCIZnaY_uF6JphoC_f5wEGx8Qsh6uQQ5jIcRnBZ-4D__8kbn6udsw</recordid><startdate>20040616</startdate><enddate>20040616</enddate><creator>Masood, Anbrin</creator><creator>Banerji, Basudeb</creator><creator>Vijayan, V.K.</creator><creator>Ray, Arunabha</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040616</creationdate><title>Pharmacological and biochemical studies on the possible role of nitric oxide in stress adaptation in rats</title><author>Masood, Anbrin ; Banerji, Basudeb ; Vijayan, V.K. ; Ray, Arunabha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-3bbb58930f3f2ecdde66b24828417be63540cedd944333afeed7acd19e571f1b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adaptation</topic><topic>Adaptation, Physiological - drug effects</topic><topic>Adaptation, Physiological - physiology</topic><topic>Animals</topic><topic>Arginine - pharmacology</topic><topic>Arginine - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Brain Chemistry - drug effects</topic><topic>Drug Evaluation, Preclinical - methods</topic><topic>Elevated plus maze</topic><topic>Indazoles - pharmacology</topic><topic>India</topic><topic>Male</topic><topic>Maze Learning - physiology</topic><topic>Medical sciences</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitric Oxide - chemistry</topic><topic>Nitric Oxide - physiology</topic><topic>Nitric Oxide Synthase - antagonists & inhibitors</topic><topic>Nitric Oxide Synthase - pharmacology</topic><topic>NO (Nitric oxide)</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Restraint, Physical - adverse effects</topic><topic>Restraint, Physical - methods</topic><topic>Stress</topic><topic>Stress, Physiological - drug therapy</topic><topic>Stress, Physiological - metabolism</topic><topic>Stress, Physiological - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Masood, Anbrin</creatorcontrib><creatorcontrib>Banerji, Basudeb</creatorcontrib><creatorcontrib>Vijayan, V.K.</creatorcontrib><creatorcontrib>Ray, Arunabha</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Masood, Anbrin</au><au>Banerji, Basudeb</au><au>Vijayan, V.K.</au><au>Ray, Arunabha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacological and biochemical studies on the possible role of nitric oxide in stress adaptation in rats</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2004-06-16</date><risdate>2004</risdate><volume>493</volume><issue>1</issue><spage>111</spage><epage>115</epage><pages>111-115</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>The involvement of nitric oxide (NO) in stress adaptation was evaluated in rats using the elevated plus maze test. Repeated restraint stress RS(×5) for 5 days resulted in an increase in the percentage number of entries and percentage time spent when compared to a single restraint stress RS(×1) exposure. In the repeated RS treatment groups, the nitric oxide donor,
l-arginine (500 and 1000 mg/kg, i.p.) slightly increased the elevated plus maze test parameters when compared to the corresponding vehicle-treated group. The nitric oxide synthase (NOS) inhibitors,
N-nitro-
l-arginine methyl ester (
l-NAME, 10 and 50 mg/kg, i.p.) and 7-nitroindazole (10 and 50 mg/kg, i.p.) produced differential responses in both the parameters with
l-NAME exhibiting greater reduction in open arm entries and open arm time, whereas 7-nitroindazole produced only small differences in both the elevated plus maze parameters. Biochemical data showed that repeated restraint stress resulted in higher levels of brain nitrates and nitrites (NO
x) as compared to that of single restraint stress exposure. Further, in
l-arginine (1000 mg/kg, i.p.)-treated rats, brain NO
x was lowest in the single restraint stress group, followed by repeated restraint stress and (no restraint stress) controls. The results are suggestive of the role of nitric oxide in stress adaptation and this may be due to the effects of restraint stress on brain NOS activity.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>15189771</pmid><doi>10.1016/j.ejphar.2004.04.018</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 2004-06, Vol.493 (1), p.111-115 |
issn | 0014-2999 1879-0712 |
language | eng |
recordid | cdi_proquest_miscellaneous_72014141 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adaptation Adaptation, Physiological - drug effects Adaptation, Physiological - physiology Animals Arginine - pharmacology Arginine - therapeutic use Biological and medical sciences Brain Chemistry - drug effects Drug Evaluation, Preclinical - methods Elevated plus maze Indazoles - pharmacology India Male Maze Learning - physiology Medical sciences NG-Nitroarginine Methyl Ester - pharmacology Nitric Oxide - chemistry Nitric Oxide - physiology Nitric Oxide Synthase - antagonists & inhibitors Nitric Oxide Synthase - pharmacology NO (Nitric oxide) Pharmacology. Drug treatments Rats Rats, Wistar Restraint, Physical - adverse effects Restraint, Physical - methods Stress Stress, Physiological - drug therapy Stress, Physiological - metabolism Stress, Physiological - physiopathology |
title | Pharmacological and biochemical studies on the possible role of nitric oxide in stress adaptation in rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T03%3A19%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacological%20and%20biochemical%20studies%20on%20the%20possible%20role%20of%20nitric%20oxide%20in%20stress%20adaptation%20in%20rats&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Masood,%20Anbrin&rft.date=2004-06-16&rft.volume=493&rft.issue=1&rft.spage=111&rft.epage=115&rft.pages=111-115&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/j.ejphar.2004.04.018&rft_dat=%3Cproquest_cross%3E72014141%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72014141&rft_id=info:pmid/15189771&rft_els_id=S0014299904004030&rfr_iscdi=true |